- Home
- VMD vs RCS Comparison
VMD vs RCS Comparison
Compare VMD & RCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | VMD | RCS |
|---|---|---|
| Founded | 2006 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.0M | 286.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VMD | RCS |
|---|---|---|
| Price | $7.35 | $6.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 133.6K | ★ 141.1K |
| Earning Date | 03-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.12% |
| EPS Growth | ★ 35.92 | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | ★ $254,794,000.00 | N/A |
| Revenue This Year | $22.48 | N/A |
| Revenue Next Year | $22.28 | N/A |
| P/E Ratio | $21.58 | ★ N/A |
| Revenue Growth | ★ 18.89 | N/A |
| 52 Week Low | $5.93 | $4.51 |
| 52 Week High | $8.62 | $6.31 |
Technical Indicators
Market Signals| Indicator | VMD | RCS |
|---|---|---|
| Relative Strength Index (RSI) | 54.86 | 43.83 |
| Support Level | $7.11 | $6.04 |
| Resistance Level | $7.60 | $6.30 |
| Average True Range (ATR) | 0.19 | 0.20 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 48.51 | 73.65 |
Price Performance
Historical ComparisonAbout VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
About RCS PIMCO Strategic Income Fund Inc.
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.